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PURPOSE. The aim of this study is to investigate modifications in human cadaver corneas after
different crosslinking procedures, including standard epi-off treatment, iontophoresis
imbibition, and different exposure to ultraviolet A (UVA) sources (30 minutes at 3 mW and
9 minutes at 10 mW).
METHODS. A total of 12 human cadaver corneas was examined and divided as follows: 3 served
as control (group 1), 3 were treated with a standard epi-off procedure (group 2), 6 underwent
iontophoresis imbibition for 5 minutes, and then 3 were irradiated for 30 minutes with 3 mW
UVA (group 3), and 3 for 9 minutes at 10 mW UVA (group 4). Deformation amplitude index
was measured before and after the corneas underwent treatment. After treatment, corneas
were prepared for hematoxylin-eosin and immunohistochemistry evaluation. The expression
of TUNEL, matrix metalloproteinase-1 (MMP-1), collagen type I, and CD34 was investigate in
all samples.
RESULTS. The deformation amplitude index decreased in all groups, in particular in group 4,
indicating an improvement of corneal biomechanical properties. Immunohistochemical
staining showed a significant stromal alteration in group 2, mild damage in group 3, and no
modifications in corneal morphology in group 4. The TUNEL (P < 0.001) and MMP-1 (P ¼
0.002) positivity was more evident in group 4. Collagen type I positivity significantly
increased in groups 3 (P ¼ 0.002) and 4 (P ¼ 0.002). The CD34 expression was more evident
in groups 2 (P ¼ 0.003) and 3 (P ¼ 0.003).
CONCLUSIONS. Iontophoresis imbibition followed by UVA irradiation for 9 minutes at 10 mW
determined less tissue damage and better stromal remodeling.
Keywords: crosslinking, keratoconus, iontophoresis
Iontophoresis is a noninvasive delivery system designed toenhance the penetration of molecules into tissue using a
small electric current. This technique is used in various fields of
medicine,1–3 including delivery of drugs to intraocular com-
partments.4,5 This system yields higher concentrations in
exposed tissue compared to a free drug solution,6 and was
adopted in ophthalmology mainly for the treatment of posterior
segment disease.4,7
Iontophoresis was proposed as a method to increase
riboflavin absorption in crosslinking (CXL) treatment.8 Corneal
CXL is a new technique introduced for the treatment of
progressive keratoconus, with the aim of increasing the
stiffness of the cornea, improving biomechanical strength,
inducing keratocyte apoptosis, and increasing resistance to
enzymatic digestion by the combined action of the photosen-
sitizer riboflavin (vitamin B2) and ultraviolet A (UVA) rays.9–14
Further indications, such as iatrogenic keratectasia,15 infectious
keratitis,16 bullous keratopathy,17 corneal ulcers,18 and pro-
gressive myopia,19 were proposed for CXL.
Riboflavin in the form used for iontophoresis is negatively
charged. It has been shown that a corneal iontophoresis
imbibition lasting five minutes achieves a sufficient ribofla-
vin concentration in corneal stroma for CXL treatment, with
the advantage of shortening the imbibition time while
preserving epithelial integrity.20 Changes in corneal struc-
ture, mainly in collagen composition and keratocyte pheno-
type, have been reported in keratoconus and after CXL
treatment.21,22
This study aimed at investigating ex vivo corneal histologic
and biomechanical modifications after CXL performed with
different imbibition and irradiation protocols, including stan-
dard technique and iontophoretic transepithelial imbibition
with various irradiation procedures.
Copyright 2014 The Association for Research in Vision and Ophthalmology, Inc.
www.iovs.org j ISSN: 1552-5783 2526
Downloaded From: http://iovs.arvojournals.org/pdfaccess.ashx?url=/data/Journals/IOVS/933472/ on 10/05/2015
MATERIALS AND METHODS
Sample Preparation
This study conformed to the tenets of the Declaration of
Helsinki. The study design is described in Figure 1A. A total of
12 human cadaver corneas was examined. The mean storage
time between eye bank procedures and crosslinking imbibi-
tions was 52 hours (range, 24–96 hours). Corneas were
randomized in 4 groups as follows: 3 untreated corneas served
as controls (group 1), 3 corneas were treated with standard
epi-off technique following the procedure described previous-
ly23 (group 2), and 6 corneas underwent iontophoresis
imbibition lasting 5 minutes with a hypoosmolar riboflavin
0.1% dextran-free solution enriched with trometamol EDTA
(Ricrolin þ; SOOFT, Montegiorgio, Italy). Of the later six
corneas, 3 (group 3) subsequently were irradiated for 30
minutes with 3 mW UVA (VEGA 3 mW; C.S.O. Srl, Firenze
Italy), and 3 (group 4) were treated for 9 minutes at 10 mW
UVA (Vega 10 mW; C.S.O. Srl). Tissue procurement and use
was carried out in accordance with local regulations. All
corneas were mounted on a disposable artificial anterior
chamber (Katena Products, Inc., Denville, NJ, USA) equipped
with a syringe filled with an eusol solution used to maintain
positive pressure, and with a steel wire that acted as the
positive pole of the circuit that connected one end to the
anterior chamber to a current generator system (I-ON CXL;
SOOFT) that permitted automated setting of treatment
duration and intensity (5 minutes, 1 mA). The same generator
connected by another cable to a steel electrode grid inserted in
a special corneal applicator (Iontofor CXL; SOOFT) that acted
as the negative pole of the circuit (Fig. 1B). The stability of the
applicator on the corneal surface was guaranteed by a system
of vacuum aspiration. The applicator was filled with riboflavin
to cover the steel grate (Fig. 1C). Before starting the imbibition,
the emission intensity of electrical continuous current was
evaluated using a suitable digital tester and fixed to 1 mA 6
5%.
Before and after treatment, all samples underwent measure-
ment of corneal deformation amplitude index (DAI) with an
Ultra High-Speed Scheimpflug noncontact air pulse tonometer
(Corvis ST; Oculus, Wetzlar, Germany). The measurement was
acquired mounting the artificial anterior chamber on a dedicated
support while maintaining an anterior chamber pressure of 10
to 18 mm Hg. The final measurement was a mean of 5
acquisitions. The DAI is a repeatable and reproducible
FIGURE 1. (A) Study design. (B) Representative image of the electric circuit used for iontophoresis imbibition. (C) Cadaver cornea mounted on
artificial anterior chamber for iontophoresis imbibition: the corneal applicator is filled with riboflavin up to the steel grate (negative pole of the
circuit).
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measurement,24 defined as the highest concavity displacement
of the corneal apex, and is an indirect measurement of corneal
biomechanical resistance (Fig. 2A, 2C, 2D).
Immediately after CXL treatment, corneas were prepared for
hematoxylin and eosin, and immunohistochemistry evaluation.
Immunohistochemistry
Formalin-fixed, paraffin-embedded serial tissue sections were
cut into 4-lm thick slices and peroxidase activity was inhibited
by immersing the slides in 3% hydrogen peroxide aqueous
solution for 5 minutes. Each sample was stained for the
following antibodies: CD34 (1:70, order number ab81289;
Abcam, Cambridge, UK), matrix metalloproteinase-1 (MMP-1,
1:50, order number ab52631; Abcam), collagen type I (1:50,
order number SAB4500363; Sigma-Aldrich, St. Louis, MO, USA),
and Apo bromodeoxyuridine (BrdU) in situ DNA fragmentation
assay kit (TUNEL, according to manufactured instruction, code
K403-50; BioVision, Inc., Milpitas, CA, USA). Tissue samples
were deparaffinized, pretreated by microwave antigen retrieval
using buffer EDTA pH9 (required for MMP-1). For all these
antigens, the En Vision system (Dako, Milano, Italy) was used
before diaminobenzidine tetrahydrochloride (Dako) incuba-
tion. A negative control was performed for each antigen using
the specific isotype control. All slides were stained for the
same antigen together with the same antigen retrieval buffer, if
required, and antibody dilution.
Evaluation of Immunoreactivity
Results were evaluated independently by two investigators in a
masked fashion. Three3200 fields covering almost the whole
sample were examined and the positive cells or positive areas
were evaluated.
Image and Statistical Analysis
Adobe Photoshop program (Adobe Systems, Inc., San Jose, CA,
USA) as described previously21,22 was used to evaluate total
and positive pixels for cytoplasmic staining (MMP-1, collagen
type I, and CD34). For nuclear staining (TUNEL) the same
software was used to count keratocytes manually to obtain
number of positive cells per area.22 A nonparametric test
(Mann-Whitney) was used to evaluate between-group differ-
ences in the mean levels of marker expression for selected
antigens (GraphPad Prism 5; GraphPad Software, Inc., San
Diego, CA, USA). Probabilities of less than 0.05 (P < 0.05) were
considered statistically significant.
RESULTS
Biomechanical Resistance Study
The results of the biomechanical resistance study are
summarized in Figure 2B. No statistical difference between
corneas of each group was recorded preoperatively in DAI
measurements.
The Corvis DAI decreased in all postoperative tests in all
groups. The greatest decrease was observed in group 4,
suggesting a more effective improvement of corneal biome-
chanical resistance in corneas treated with iontophoresis
imbibition and irradiation at 10 mW lasting 9 minutes.
Morphologic Evaluation
Morphologic evaluation of corneal modification induced by
different CXL procedures was performed analyzing hematox-
ylin and eosin–stained samples (not shown). An evident
alteration of normal collagen architecture was observed in all
FIGURE 2. (A) Example of results obtained with CORVIS: the ‘‘Deform. Amplitude’’ (bottom right) represents an index of corneal maximum
deformation amplitude at corneal apex. (B) Variation of Deformation Amplitude Index among groups between untreated (white columns) and
treated (black columns) values. Data are expressed as mean6 SD. No statistically significant difference was observed between untreated corneas of
each group. After different CXL procedures no significant variation of DAI was observed. (C, D) Representative images obtained with CORVIS of the
same cornea before (C) and after (D) treatment.
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corneas treated with standard epi-off procedure (group 2).
Normal orientation and definition of collagen lamellae was lost,
and a diffuse suffusion of stromal edema was present mainly in
anterior and middle stroma.
Group 3 showed marked signs of epithelial damage and
edema infiltration in the anterior stroma that was less evident
than that described for group 2.
Group 4 did not show epithelial alteration, and stromal
collagen conserved the normal orientation and structure.
The apoptotic cells, evaluated with TUNEL assay, were
distributed in the stroma of treated corneas. We observed a
similar number of positive cells in controls and group 2 (Fig.
3A), in contrast to the significant increase observed in groups 3
(P ¼ 0.0337) and 4 (P ¼ 0.0004) (Fig. 3B), suggesting that
treatment with iontophoresis imbibition increases keratocyte
apoptosis.
To evaluate corneal degradation and thinning induced by
iontophoresis treatment, quantification of MMP-1 expression
was done (Fig. 4A). We observed a significantly higher
expression of MMP-1 in group 4 compared to untreated
corneas (P ¼ 0.0238). No differences were observed between
group 1, and groups 2 and 3 (Fig. 4B). These results suggested
that the treatment with iontophoresis and irradiation at 10 mW
was able to stimulate significantly stromal fibroblasts and
corneal remodeling for reestablishing a normal cornea.25
To analyze the collagen fiber diameter, immunohistochem-
ical staining with anticollagen type I antibody was done (Fig.
5A). The statistically significant increase in collagen fiber
thickness in both iontophoresis imbibition groups (group 3, P
¼ 0.0018 and group 4, P ¼ 0.0018; versus control, Fig. 5B)
suggested that these treatments affected the mechanical
properties of corneal collagen tissue.
The CD34 staining was used to study the stromal
keratocytes of cornea and showed the presence of these cells
in the entire thickness of the cornea (Fig. 6A). A statistically
significant increase of CD34 was observed in groups 2 (P ¼
0.0028) and 3 (P ¼ 0.0028) compared to normal controls. On
the other hand, a significant difference was not observed for
group 4 (Fig. 6B). This result suggested that a reestablishing of
the normal corneal structure can be obtained with iontopho-
resis imbibition and irradiation at 10 mW.
DISCUSSION
It has been reported that a sufficient concentration of
riboflavin in corneal stroma was essential to obtain a
biomechanical effect of corneal CXL.26 It is known that intact
epithelium constituted a diffusion barrier for riboflavin27;
therefore, in traditional CXL protocol corneal epithelium must
be removed before the application of drug solution. However,
preserving the corneal epithelial layer can represent an
important clinical advantage because it would reduce intraop-
erative and postoperative pain, possibly avoid the need of a
therapeutic contact lens, and reduce infection-related compli-
cations and the risk of loss of corneal transparency due to
abnormal scarring processes.13,28 The possibility of performing
transepithelial treatments has been introduced recently to
clinical practice to obtain these advantages.29,30 The penetra-
tion of riboflavin through the epithelium can be increased by
different strategies, including increasing contact time, the
intercellular permeability, or altering physicochemical proper-
ties of the riboflavin solution.20 It was shown recently that
during a 5-minute iontophoresis imbibition, a sufficient
riboflavin concentration can be obtained in the stroma for
CXL treatment, thus combining the advantage of preserving
epithelium integrity while shortening treatment time.20
FIGURE 3. (A) Assessment of TUNEL-positive cells (arrows) in the experimental groups evaluated with immunohistochemistry. The images are
representative of a single experiment. Each section was counterstained with hematoxylin (3400). (B) Statistical analysis of data obtained from
different samples. TUNEL-positive cells were identified by counting the number of cells showing an intense immune-labeling in three3200 fields
from each sample. Data are expressed as mean 6 SD. The Mann-Whitney test was used to evaluate between-group differences in the mean levels of
marker expression. *P ¼ 0.0337, ***P¼ 0.0004 versus control.
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FIGURE 5. (A) Immunohistochemistry evaluation of collagen type I expression in experimental groups. A strong expression of collagen type I was
observed in group 4. Hematoxylin counterstained (3200). (B) Computer-assisted quantification of fiber size using Adobe Photoshop in three fields
(3200) for each sample. The Mann-Whitney test was used to evaluate between-group differences in the mean levels of marker expression. **P and
***P ¼ 0.0018 versus control.
FIGURE 4. (A) Expression of MMP-1 (arrows) in experimental groups evaluated by immunohistochemistry. A significant expression of MMP-1
was observed in corneas of group 4, while the percentage of positive areas in the second and third groups are similar to the control.
Hematoxylin counterstained (3200). (B) Computer-quantification of MMP-1 staining using Adobe Photoshop software in three fields (3200) for
each sample. The Mann-Whitney test was used to evaluate between-group differences in the mean levels of marker expression. *P ¼ 0.0238
versus control.
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In this study the real effect of different CXL procedures was
investigated in terms of changes in corneal biomechanical
properties and tissue modifications induced by treatment.
The Corvis ST is a new clinical instrument for corneal
deformation assessment using an ultra high-speed Scheimpflug
technology incorporated in a noncontact tonometer. The few
first reports presented in the literature show a very good
repeatability of IOP and central corneal thickness measured by
this device, while discordant results were reported for the DAI
and the first A-time applanation.24,31,32 The DAI is a repeatable
parameter that evaluates corneal elasticity and resistance by
analyzing dynamic morphologic modifications in response to a
mechanical pressure stimulus.24 The measurement of DAI was
performed in treated corneas and preoperative values were
comparable in each groups. The results showed a reduction of
DAI in all groups after CXL treatment, indicating an increase of
corneal biomechanical rigidity in all treated corneas. This trend
of reduction was more evident in corneas treated with
iontophoretic imbibition and 9 minutes of 10 mW irradiation,
even if this difference was not statistically significant.
A previous ex vivo study on porcine corneas33 showed, in
corneas stored in different medium, that hydration and
preservation change corneal biomechanics, in particular its
relaxation over a period of 24 hours. Our corneas were stored
in the same medium, so this influence is not dissimilar among
the groups. After treatment, stromal edema was particularly
evident in group 2. This element may explain the unexpected
result of a lower improvement of corneal rigidity in epi-off CXL
that theoretically is related with a higher rate of riboflavin
penetration.27 Moreover, it’s already known that corneal
curvature and thickness affect corneal rigidity,34 but possible
preoperative differences among our samples were not as
important to generate a significant difference of DAI in
experimental groups. The poor and not significant differences
observed after CXL treatment are so likely related to the
procedure. However, the smallness of the groups, the variation
of IOP among the acquisitions, and differences in corneal
characteristics or storage procedures affect the reliability of the
reported results.
These preliminary results suggested that CXL treatment was
effective in improving corneal biomechanical resistance to
ectatic processes, but this finding must be confirmed in a larger
number of samples. Moreover, it will be extremely interesting
to evaluate if these differences also will be observed in vivo
with DAI evaluation.
Morphologic analysis of corneas treated with standard
procedure shows an evident damage to stromal structure with
significant alteration of normal fiber architecture and presence
of edema. These results were in accordance with in vivo
findings using confocal microscopy that revealed an evident
inflammatory response after traditional treatment.35 In group 3
epithelial damage was observed, while in group 4 alterations in
corneal morphology were not found, suggesting that epithelial
damage was caused mainly by the irradiation procedure, the
only difference between the two groups. However, the
integrity and permeability of corneal epithelium are affected
by the storage time that could have influenced the results
obtained in groups 3 and 4.
Previous studies on rabbit corneas26,36 demonstrated that
riboflavin/UVA crosslinking leads to a dose-dependent damage
with keratocyte apoptosis, probably due to accumulation of
oxygen species.36 Keratocyte apoptosis was massive when
analyzed 24 hours after treatment followed by a gradual
repopulation process of the anterior corneal stroma.36 These
results were confirmed in human corneas treated with
traditional CXL, in which an overexpression of TUNEL and
ki67 was observed, indicating that CXL treatment stimulated
keratocytes apoptosis and repopulation.21 Our study in human
specimens showed a more evident keratinocytes apoptosis in
CXL treatment with iontophoresis imbibition and, in particular,
FIGURE 6. (A) CD34 expression in experimental groups detected in keratocytes of the entire corneal stroma observed with immunohistochemistry.
In group 4 CD34-positivity is lost in small areas that are most frequently located in the anterior stroma. Hematoxylin counterstained (3200). (B)
Computer-assisted quantification of CD34 staining using Adobe Photoshop in three fields (3200) for each sample. The Mann-Whitney test was used
to evaluate between-group differences in the mean levels of marker expression. **P ¼ 0.0028 versus control.
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after the irradiation at 10 mW. It is known that keratoconus is a
noninflammatory ectasia of the cornea with documented
changes of the corneal epithelial basement membrane, in
extracellular matrix components, in keratocyte morphology, of
cell–matrix interactions, and in stromal collagen composition,
distribution, and organization (that can lead to lamellar and/or
fibrillar slippage). However, the underlying pathologic mech-
anisms still are poorly understood. It was suggested that
corneal degradation and thinning in keratoconus are caused
mainly by MMPs. In normal cornea, MMP-1 was seen only in
some of the epithelial cells, which were weakly positive,
indicating a relatively low level of expression.25 In keratoco-
nus, MMP-1 was seen in a larger proportion of epithelial cells
and staining was relatively intense.25 To the best of our
knowledge, for the first time the expression of MMP-1 was
investigated in human corneas after CXL treatment. We
observed an upregulation of this marker only in group 4,
probably due to matrix remodeling induced by the specific
treatment. We observed this effect immediately after the
procedure and it would be interesting to analyze if the level
of MMP-1 decreased over time.
Mencucci et al.21 noticed a statistically significant increase
in corneal collagen fiber diameter in the anterior stroma in
traditional CXL-treated corneas, probably due to the physical
CXL action. This indicated the increased biomechanical
stiffness of the cornea after the treatment. In groups 3 and 4
analyzed immediately after treatment, we observed the same
increase of collagen type I expression that already was
described for corneas 6 months after therapy.21 These
preliminary data suggest that iontophoresis imbibition led to
reshaping of collagen fibers with increased resistance to ectatic
processes.
The stem cell marker CD34 is expressed strongly by human
corneal keratocytes.37 It was supposed that CD34 has a role in
cytoadhesion and signaling related to differentiation and
proliferation.38 Interestingly, the treatment with iontophoresis
imbibition and irradiation at 10 mW was able to reduce the
number of CD34-positive cells that became similar to the one
present in control corneas. According to data obtained by
Mencucci et al.,21 in human cornea the apoptotic keratocytes
may be replaced by precursor cells that may be activated by
specific stimuli and that can readily respond to regenerate
native corneal stroma, thus, restoring transparence.
Our data on iontophoresis imbibition and 10 mW
irradiation lasting 9 minutes showed that this procedure is
likely able to reestablish a close to normal structure of corneal
stroma. To the best of our knowledge this study represents
the first report of early corneal modifications after CXL with
iontophoretic imbibition and investigates differences among
surgical procedures; in fact, to our knowledge the only two
studies about iontophoresis imbibition and corneal CXL
already published in the literature concern clinical parame-
ters39 and quantification of riboflavin penetration after
different imbibition strategies.40
However, in this study specimens were analyzed immedi-
ately after the treatment, and we observed the same positivity
grade with a good replicate in three different corneas per
group, collected at the same time after death. Probably, this
finding is the result of a tissue modification that occurs during
and immediately after the procedure. Of course, it will be of
interest to analyze in vivo differences in long-term corneal
response that can be related to the efficacy of each CXL
procedure to set up the best method for clinic routine.
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